These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6109034)

  • 1. Correlation between vasodilator potencies of beta-adrenoceptor blocking drugs and their chemical structures.
    Himori N
    Jpn J Pharmacol; 1980 Apr; 30(2):255-8. PubMed ID: 6109034
    [No Abstract]   [Full Text] [Related]  

  • 2. Beta-adrenergic blocking property of l-3-methoxy-omega-(1-hydroxy-1-phenylisopropylamino)-propiophenone-HCL (D 563) in femoral circulation.
    Sakai K
    Jpn J Pharmacol; 1970 Jun; 20(2):306-7. PubMed ID: 4393950
    [No Abstract]   [Full Text] [Related]  

  • 3. Adrenergic mechanisms in canine hindlimb circulation.
    Brungardt JM; Swan KG; Reynolds DG
    Cardiovasc Res; 1974 May; 8(3):423-9. PubMed ID: 4153267
    [No Abstract]   [Full Text] [Related]  

  • 4. Structure-selectivity relationships of beta-adrenoceptor antagonists in cats.
    Zakhari S
    Eur J Pharmacol; 1974 Nov; 29(1):22-9. PubMed ID: 4154860
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of catecholamines and adrenoceptor blocking drugs on the canine peripheral lymph flow.
    De Micheli P; Glässer AH
    Br J Pharmacol; 1975 Apr; 53(4):499-504. PubMed ID: 238702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of some beta-adrenergic blocking drugs on the renal bloow flow in dogs.
    Abdel-Razzak M
    Arch Int Pharmacodyn Ther; 1977 Oct; 229(2):227-34. PubMed ID: 23082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular effects of a novel calcium entry blocking and selective beta 1-adrenoceptor blocking agent, YM-16151-4, in anesthetized and conscious dogs.
    Uchida W; Shibasaki K; Asano M
    J Cardiovasc Pharmacol; 1992 Jan; 19(1):60-8. PubMed ID: 1375689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of Doppler ultrasound techniques to study the effects of isoprenaline and beta-adrenoceptor blocking drugs on peripheral blood vessels in man.
    Fitzgerald DE; Harry JD
    Br J Clin Pharmacol; 1984 Jun; 17(6):773-6. PubMed ID: 6146331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterocyclic analogues of the antihypertensive beta-adrenergic blocking agent (S)-2-[3-(ter-butylamino)-2-hydroxypropoxy]-3-cyanopyridine.
    Baldwin JJ; Engelhardt EL; Hirschmann R; Ponticello GS; Atkinson JG; Wasson BK; Sweet CS; Scriabine A
    J Med Chem; 1980 Jan; 23(1):65-70. PubMed ID: 6102151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamic and pharmacokinetic studies on prizidilol and nipradilol (K-351), antihypertensive drugs with combined vasodilator and beta-adrenoceptor blocking actions, in rabbits.
    Kawashima K; Watanabe TX; Sokabe H
    Jpn J Pharmacol; 1984 Dec; 36(4):519-26. PubMed ID: 6151998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasodilating beta-adrenoceptor blocking drugs do not redistribute myocardial flow during acute coronary ligation in dogs.
    Berdeaux A; Bonhenry C; Giudicelli JF
    Eur J Pharmacol; 1985 Jun; 112(3):379-85. PubMed ID: 2862054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vanidipinedilol: a vanilloid-based beta-adrenoceptor blocker displaying calcium entry blocking and vasorelaxant activities.
    Yeh JL; Liou SF; Liang JC; Huang YC; Chiang LC; Wu JR; Lin YT; Chen IJ
    J Cardiovasc Pharmacol; 2000 Jan; 35(1):51-63. PubMed ID: 10630733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the mechanism of the acute antihypertensive and vasodilator actions of several beta-adrenoceptor antagonists.
    Sybertz EJ; Baum T; Pula KK; Nelson S; Eynon E; Sabin C
    J Cardiovasc Pharmacol; 1982; 4(5):749-58. PubMed ID: 6182405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-adrenergic receptor blocking drugs in hypertension.
    Simpson FO
    Drugs; 1974; 7(1):85-105. PubMed ID: 4152167
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on the stereoisomers of beta-adrenoceptor antagonists in conscious A-V blocked dogs.
    Boucher M; Duchêne-Marullaz P; Moundanga JL
    Br J Pharmacol; 1986 Sep; 89(1):119-27. PubMed ID: 2879587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of peripheral vascular responses to isoprenaline by three beta-adrenoceptor antagonists in the anaesthetized dog.
    Hainsworth R; Karim F; Stoker JB
    Br J Pharmacol; 1974 Jun; 51(2):161-8. PubMed ID: 4155969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of a combined arteriolar dilator and beta-adrenoceptor antagonist (SK & F 92657) in the peripheral vessels of man.
    Collier JG; Pitcher DW
    Br J Clin Pharmacol; 1980 Dec; 10(6):567-71. PubMed ID: 6110437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interplay of vasodilator and vasoconstrictor substances in the femoral arterial bed: identification of the angiotensin cofactor.
    Haas E; Goldblatt H; Lewis L; Gipson EC
    Lab Invest; 1973 Jan; 28(1):1-7. PubMed ID: 4347553
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of etafenone on the coronary and femoral circulations before and after adrenergic -blockade in intact dogs.
    Raberger G; Weissel M
    Pharmacology; 1972; 7(4):264-70. PubMed ID: 4403998
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacological properties of the stereoisomers of prizidilol: their use in analysis of reflex tachycardia and blood pressure control in normotensive cats, rats, and dogs.
    Owen DA; Eden RJ; Lamb MS; Taylor EM
    J Cardiovasc Pharmacol; 1986; 8(4):743-8. PubMed ID: 2427813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.